Literature DB >> 2452916

[Intrahepatic cholestasis and aplastic anemia following administration of prajmaline].

R Lenzen1, H Gottesbüren, F Borchard, M Wienbeck, G Strohmeyer.   

Abstract

Intrahepatic cholestasis and aplastic anemia after N-propylajmaline. A 43 year old female patient taking oral contraceptives for more than five years received the antiarrhythmic drug N-propylajmaline for treatment of ventricular arrhythmia. After twelve days (total dosage 510 mg N-propyl-ajmaline) acute severe intrahepatic cholestasis and aplastic anemia developed. The erythropoeisis improved after three weeks of treatment with corticosteroids. However, despite treatment with phenobarbital the jaundice receded very slowly. Even after nine years of follow-up cholestatic enzymes are still significantly elevated although serum bilirubin levels are in the normal range. This case report demonstrates that antiarrhythmic drugs may induce nearly irreversible intrahepatic cholestasis and severe hematological disturbances.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452916     DOI: 10.1007/bf01748169

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  16 in total

1.  [Intrahepatic cholestasis caused by prajmalium bitartrate].

Authors:  H Pantlen
Journal:  Dtsch Med Wochenschr       Date:  1976-12-10       Impact factor: 0.628

2.  Agranulocytosis associated with ajmalin therapy.

Authors:  J H Wilson; T Cazemier; H O Nieweg
Journal:  Acta Med Scand       Date:  1971 Jul-Aug

3.  Oral contraceptives and other risk factors for gallbladder disease.

Authors:  B L Strom; R N Tamragouri; M L Morse; E L Lazar; S L West; P D Stolley; J K Jones
Journal:  Clin Pharmacol Ther       Date:  1986-03       Impact factor: 6.875

4.  [Prajmalium bitartrat-induced liver damage (author's transl)].

Authors:  H Lindner; D Weber; G Klöppel
Journal:  Dtsch Med Wochenschr       Date:  1976-12-17       Impact factor: 0.628

5.  [Intrahepatic cholestasis due to N-propyl ajmaline].

Authors:  H P Buscher; H Talke; H P Rademacher; U Gessner; W Oehlert; W Gerok
Journal:  Dtsch Med Wochenschr       Date:  1976-04-30       Impact factor: 0.628

Review 6.  Cholestatic jaundice associated with chlordiazepoxide hydrochloride (Librium) therapy. Report of a case and review of the literature.

Authors:  K J Lo; I R Eastwood; S Eidelman
Journal:  Am J Dig Dis       Date:  1967-08

7.  [Liver damage due to N-propyl-ajmalin bitartrate (NPAB)].

Authors:  H Henning; H M Vogel; J Ihlenfeld; K Buchegger; C J Lüders
Journal:  Z Gastroenterol       Date:  1975-09       Impact factor: 2.000

8.  Evaluation of prajmalium-induced cholestasis by immunologic tests.

Authors:  H H Rotmensch; A Leiser; M Dan; A Klejman; E Livni; B Ilie; G Messer; U Kadish; M Liron
Journal:  Arch Intern Med       Date:  1981-12

Review 9.  Drug effects on the liver. An updated tabular compilation of drugs and drug-related hepatic diseases.

Authors:  J Ludwig; R Axelsen
Journal:  Dig Dis Sci       Date:  1983-07       Impact factor: 3.199

10.  Transient cholestasis during treatment with ajmaline, and chronic xanthomatous cholestasis after administration of ajmaline, methyltestosterone and ethinylestradiol. Two case reports.

Authors:  B Beermann; J L Ericsson; K Hellström; B Wengle; B Werner
Journal:  Acta Med Scand       Date:  1971-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.